Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Malignant peripheral nerve sheath tumor development during MEK inhibitor treatment: A pre-clinical study and a clinical case series.
Journal: Neuro-oncology advances
Published: April 27, 2026
A Pilot Study of Plasma Cell-Free DNA Fragmentomics in Gallbladder Cancer.
Journal: JHEP reports : innovation in hepatology
Published: December 09, 2025
Integrated Multiclass Driver ctDNA Profiling Enables MPNST Detection and Monitoring in NF1 Patients.
Integrated Multiclass Driver ctDNA Profiling Enables MPNST Detection and Monitoring in NF1 Patients.
Journal: Research square
Published: November 19, 2025
Integrated multiclass driver ctDNA profiling enables MPNST detection and monitoring in NF1 patients.
Integrated multiclass driver ctDNA profiling enables MPNST detection and monitoring in NF1 patients.
Journal: NPJ precision oncology
Published: August 08, 2025
SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 01, 2025
SARC031: A Phase 2 Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 01, 2025
Brain Metastasis in Pediatric Patients with Osteosarcoma.
Journal: Current oncology (Toronto, Ont.)
Published: September 30, 2024
Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 12, 2024
Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials.
Journal: Clinical trials (London, England)
Published: October 31, 2023
Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.
Journal: JAMA dermatology
Published: August 16, 2023
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 24, 2023
Last Updated: 09/26/2026